Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Watch our virtual coverage of the 16th European Epilepsy Congress (EEC 2026), which took place in Athens, Greece.

EEC 2026

The 16th European Epilepsy Congress
05–09 September 2026 | Virtual Meeting

EEC 2026

The 16th European Epilepsy Congress
05–09 September 2026 | Virtual Meeting
Watch our virtual coverage of the 16th European Epilepsy Congress (EEC 2026), which took place in Athens, Greece.
Which emerging epilepsy therapies are likely to change clinical practice? 9:12
Which emerging epilepsy therapies are likely to change clinical practice?
William Alves Martins • 20 Oct 2026
Emerging gene therapies for Dravet syndrome and other DEEs 10:41
Emerging gene therapies for Dravet syndrome and other DEEs
William Alves Martins • 20 Oct 2026
Emerging precision therapies reshaping the antiseizure medication landscape in epilepsy 9:58
Emerging precision therapies reshaping the antiseizure medication landscape in epilepsy
William Alves Martins • 20 Oct 2026
Phase II/III POWER1: efficacy, safety and lessons learned for vormatrigine in epilepsy 8:05
Phase II/III POWER1: efficacy, safety and lessons learned for vormatrigine in epilepsy
William Alves Martins • 20 Oct 2026
The Phase III GEMZ trial of fenfluramine in CDKL5 deficiency disorder 2:10
The Phase III GEMZ trial of fenfluramine in CDKL5 deficiency disorder
Nicola Specchio • 28 Sep 2026
Early diagnosis and multidisciplinary care in developmental and epileptic encephalopathies 3:00
Early diagnosis and multidisciplinary care in developmental and epileptic encephalopathies
Nicola Specchio • 28 Sep 2026
What defines a disease-modifying therapy in Dravet syndrome and other DEEs? 3:02
What defines a disease-modifying therapy in Dravet syndrome and other DEEs?
Nicola Specchio • 28 Sep 2026
Rare and ultra-rare epilepsies: managing complexities as a clinician 2:50
Rare and ultra-rare epilepsies: managing complexities as a clinician
Nicola Specchio • 28 Sep 2026
Understanding Dravet syndrome biology to advance disease-modifying therapies 2:31
Understanding Dravet syndrome biology to advance disease-modifying therapies
Nicola Specchio • 28 Sep 2026
Psychiatric comorbidities in epilepsy: identifying, monitoring, and treatment considerations 2:45
Psychiatric comorbidities in epilepsy: identifying, monitoring, and treatment considerations
Jakob Christensen • 11 Sep 2026
Reproductive health in males with epilepsy: the impact of antiseizure medications 2:29
Reproductive health in males with epilepsy: the impact of antiseizure medications
Jakob Christensen • 11 Sep 2026
Recognizing the burden of secondary epilepsy in global health estimates 2:15
Recognizing the burden of secondary epilepsy in global health estimates
Jakob Christensen • 11 Sep 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals